DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cancidas (Caspofungin) - Renal Failure Acute - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Renal Failure Acute (15)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cancidas (Caspofungin) where reactions include renal failure acute. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Cancidas side effects in 15 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-07

Patient: 15 year old female

Reactions: Overdose, Drug Interaction, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Bactrim
    Dosage: 1 df, three times per week
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Dosage: unk
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin HCL
    Dosage: unk
    Start date: 2012-05-28
    End date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, 3x/day
    Start date: 2012-05-28
    End date: 2012-06-04

Gentamicin
    Dosage: unk
    Start date: 2012-05-26
    End date: 2012-05-30

Other drugs received by patient possibly interacting with the suspect drug:
Neoral
    Dosage: 100 mg, 2x/day
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-05-31

Vancomycin HCL
    Dosage: 1 g, 2x/day
    Start date: 2012-05-22
    End date: 2012-06-03

Vfend
    Dosage: 200 mg, 2x/day
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-25

Vfend
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    End date: 2012-05-31

Other drugs received by patient: Colistin; Gentamicin; Neupogen



Possible Cancidas side effects in 15 year old female

Reported by a individual with unspecified qualification from Ireland on 2012-08-06

Patient: 15 year old female

Reactions: Nephropathy Toxic, Drug Interaction, Multiple Drug Overdose, Respiratory Distress, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cancidas
    Dosage: ; iv
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-05-30

Cyclosporine
    Dosage: 200 mg; ;po
    Administration route: Oral
    Indication: Aplasia
    Start date: 2012-04-23
    End date: 2012-05-31

Gentamicin
    Dosage: 170 ug; ;iv
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-26
    End date: 2012-05-30

Ticarcillin Disodium / Clavulanate Potassium (Claventin / 00973701 / )
    Dosage: ; iv
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-06-01

Trimethoprim + Sulfamethoxazole
    Dosage: ; tid; iv
    Indication: Prophylaxis
    Start date: 2012-04-01

Vancomycin
    Dosage: 2 gm; iv
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-22

Voriconazole
    Dosage: ; iv
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-31

Other drugs received by patient: Colistin; Atgam; Ciprofloxacin; Filgrastim



Possible Cancidas side effects in 15 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01

Patient: 15 year old female

Reactions: Overdose, Drug Interaction, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Bactrim
    Dosage: 1 df, three times per week
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Dosage: unk
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin HCL
    Dosage: unk
    Start date: 2012-05-28
    End date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, 3x/day
    Start date: 2012-05-28
    End date: 2012-06-04

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
    Dosage: unk
    Start date: 2012-05-26
    End date: 2012-05-30

Neoral
    Dosage: 100 mg, 2x/day
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-05-31

Vancomycin HCL
    Dosage: 1 g, 2x/day
    Start date: 2012-05-22
    End date: 2012-06-03

Vfend
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    End date: 2012-05-31

Vfend
    Dosage: 200 mg, 2x/day
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-25

Other drugs received by patient: Colistin; Neupogen; Gentamicin



Possible Cancidas side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01

Patient:

Reactions: Overdose, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Bactrim
    Dosage: 1 df, tiw
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-04-01

Cancidas
    Dosage: unk
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-05-30

Ciproflaxacin
    Dosage: unk
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, tid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-06-04

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
    Dosage: unk
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-26
    End date: 2012-05-30

Neoral
    Dosage: 100 mg, bid
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-05-31

Vancomycin
    Dosage: 2250 mg, qd
    Start date: 2012-05-01
    End date: 2012-05-01

Vancomycin
    Dosage: 2000 mg, qd
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-22
    End date: 2012-05-01

Vancomycin
    Dosage: 1800 mg, qd
    Start date: 2012-05-01
    End date: 2012-06-03

Vfend
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2012-05-26
    End date: 2012-05-31

Vfend
    Dosage: 200 mg, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-25

Other drugs received by patient: Neupogen



Possible Cancidas side effects in female

Reported by a physician from France on 2012-07-27

Patient: female

Reactions: Face Oedema, Oedema Peripheral, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Bactrim
    Dosage: 1unit three times per week
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin HCL
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-28
    End date: 2012-06-04

Clavulanate Potassium
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-06-01

Gentamicin
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-26
    End date: 2012-05-30

Neoral
    Dosage: 100mg twice per day
    Administration route: Oral
    Indication: Aplasia
    Start date: 2012-04-23
    End date: 2012-05-31

Vancomycin
    Dosage: 1g twice per day
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-22

Vfend
    Dosage: 200mg twice per day
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-31

Other drugs received by patient: Atgam; Colistine; Neupogen



Possible Cancidas side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26

Patient: female

Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Hepatic Failure, Drug Interaction, Respiratory Distress, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-25
    End date: 2012-04-27

Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-23

Bactrim
    Dosage: 1 df, qw3
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin
    Start date: 2012-05-28
    End date: 2012-06-06

Clavulanate Potassium
    Dosage: unk
    Start date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, tid
    Start date: 2012-05-28
    End date: 2012-06-01

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin

Neoral
    Dosage: 1 df, bid
    Administration route: Oral
    Start date: 2012-04-23

Vancomycin
    Dosage: 1 g, bid
    Start date: 2012-05-22

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-05-25

Vancomycin
    Dosage: 1800 mg, unk
    Start date: 2012-06-06

Vancomycin
    Dosage: 2250 mg, unk
    Start date: 2012-05-31

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-06-04

Vfend
    Administration route: Oral

Vfend
    Dosage: 1 df, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-31

Other drugs received by patient: Colistin; Neupogen



Possible Cancidas side effects in 15 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26

Patient: 15 year old female

Reactions: Drug Interaction, Multiple Drug Overdose, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Cancidas
    Dosage: iv
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-28
    End date: 2012-06-04

Cyclosporine
    Dosage: 200 mg;po
    Administration route: Oral
    Indication: Aplasia
    Start date: 2012-04-23
    End date: 2012-05-31

Gentamicin
    Dosage: 170 ug;iv
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-26
    End date: 2012-05-30

Ticarcillin Disodium / Clavulanate Potassium (Claventin / 00973701 / )
    Dosage: iv
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-06-01

Trimethoprim + Sulfamethoxazole
    Dosage: tid;iv
    Indication: Prophylaxis
    Start date: 2012-04-01

Vancomycin
    Dosage: 2 gm;iv
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-22

Voriconazole
    Dosage: 400 mg;iv
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-31

Other drugs received by patient: Filgrastim; Colistin; Atgam



Possible Cancidas side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26

Patient:

Reactions: Overdose, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Bactrim
    Dosage: 1 df, tiw
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-04-01

Cancidas
    Dosage: unk
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-05-30

Ciproflaxacin
    Dosage: unk
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, tid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-06-04

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
    Dosage: unk
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-26
    End date: 2012-05-30

Neoral
    Dosage: 100 mg, bid
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-05-31

Vancomycin
    Dosage: 2250 mg, qd
    Start date: 2012-05-01
    End date: 2012-05-01

Vancomycin
    Dosage: 1800 mg, qd
    Start date: 2012-05-01
    End date: 2012-06-03

Vancomycin
    Dosage: 1000 mg, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-22
    End date: 2012-05-01

Vfend
    Dosage: 200 mg, bid
    Start date: 2012-05-14
    End date: 2012-05-31

Vfend
    Dosage: 200 mg, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-25

Other drugs received by patient: Neupogen



Possible Cancidas side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26

Patient: female

Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Respiratory Distress, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-25
    End date: 2012-04-27

Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-23

Bactrim
    Dosage: 1 df, qw3
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Start date: 2012-05-28
    End date: 2012-05-30

Ciproflaxacin
    Start date: 2012-05-28
    End date: 2012-06-06

Clavulanate Potassium
    Dosage: 1 df, tid
    Start date: 2012-05-28
    End date: 2012-06-01

Clavulanate Potassium
    Dosage: unk
    Start date: 2012-06-04

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin

Neoral
    Dosage: 1 df, bid
    Administration route: Oral
    Start date: 2012-04-23

Vancomycin
    Dosage: 1 g, bid
    Start date: 2012-05-22

Vancomycin
    Dosage: 2250 mg, unk
    Start date: 2012-05-31

Vancomycin
    Dosage: 1800 mg, unk
    Start date: 2012-06-06

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-06-04

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-05-25

Vfend
    Administration route: Oral

Vfend
    Dosage: 1 df, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-31

Other drugs received by patient: Colistin; Neupogen



Possible Cancidas side effects in female

Reported by a physician from France on 2012-07-20

Patient: female

Reactions: Face Oedema, Oedema Peripheral, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Bactrim
    Dosage: 1unit three times per week
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin HCL
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-28
    End date: 2012-06-04

Clavulanate Potassium
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-28
    End date: 2012-06-01

Gentamicin
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-26
    End date: 2012-05-30

Neoral
    Dosage: 100mg twice per day
    Administration route: Oral
    Indication: Aplasia
    Start date: 2012-04-23
    End date: 2012-05-31

Vancomycin
    Dosage: 1g twice per day
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-22

Vfend
    Dosage: 200mg twice per day
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-31

Other drugs received by patient: Atgam; Colistine; Neupogen



Possible Cancidas side effects in 15 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-20

Patient: 15 year old female

Reactions: Overdose, Drug Interaction, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Bactrim
    Dosage: 1 df, three times per week
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Dosage: unk
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin HCL
    Dosage: unk
    Start date: 2012-05-28
    End date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, 3x/day
    Start date: 2012-05-28
    End date: 2012-06-04

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin
    Dosage: unk
    Start date: 2012-05-26
    End date: 2012-05-30

Neoral
    Dosage: 100 mg, 2x/day
    Administration route: Oral
    Start date: 2012-04-23
    End date: 2012-05-31

Vancomycin
    Dosage: 1 g, 2x/day
    Start date: 2012-05-22
    End date: 2012-06-03

Vfend
    Dosage: 200 mg, 2x/day
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-25

Vfend
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    End date: 2012-05-31

Other drugs received by patient: Neupogen; Colistin; Gentamicin



Possible Cancidas side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-17

Patient: female

Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-23

Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-25
    End date: 2012-04-27

Bactrim
    Dosage: 1 df, qw3
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin
    Start date: 2012-05-28
    End date: 2012-06-06

Clavulanate Potassium
    Dosage: 1 df, tid
    Start date: 2012-05-28
    End date: 2012-06-01

Clavulanate Potassium
    Dosage: unk
    Start date: 2012-06-04

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin

Neoral
    Dosage: 1 df, bid
    Administration route: Oral
    Start date: 2012-04-23

Vancomycin
    Dosage: 1 g, bid
    Start date: 2012-05-22

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-05-25

Vancomycin
    Dosage: 2250 mg, unk
    Start date: 2012-05-31

Vancomycin
    Dosage: 1800 mg, unk
    Start date: 2012-06-06

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-06-04

Vfend
    Administration route: Oral

Vfend
    Dosage: 1 df, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-31

Other drugs received by patient: Colistin; Neupogen



Possible Cancidas side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-16

Patient: female

Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-23

Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-25
    End date: 2012-04-27

Bactrim
    Dosage: 1 df, qw3
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin
    Start date: 2012-05-28
    End date: 2012-06-06

Clavulanate Potassium
    Dosage: unk
    Start date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, tid
    Start date: 2012-05-28
    End date: 2012-06-01

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin

Neoral
    Dosage: 1 df, bid
    Administration route: Oral
    Start date: 2012-04-23

Vancomycin
    Dosage: 1800 mg, unk
    Start date: 2012-06-06

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-06-04

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-05-25

Vancomycin
    Dosage: 2250 mg, unk
    Start date: 2012-05-31

Vancomycin
    Dosage: 1 g, bid
    Start date: 2012-05-22

Vfend
    Dosage: 1 df, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-31

Vfend
    Administration route: Oral

Other drugs received by patient: Colistin; Neupogen



Possible Cancidas side effects in female

Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-03-06

Patient: female, weighing 1.0 kg (2.2 pounds)

Reactions: Multi-Organ Failure, Hyperkalaemia, Cholestasis, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cancidas

Cancidas
    Dosage: on the 21st day
    Indication: Candidiasis



Possible Cancidas side effects in female

Reported by a physician from Taiwan, Province of China on 2012-02-28

Patient: female, weighing 1.0 kg (2.2 pounds)

Reactions: Death, Hyperkalaemia, Cholestasis, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cancidas
    Indication: Candidiasis

Cancidas

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017